Company page

Alector, Inc.

Alector, Inc. is a public biotechnology company based in America, focused on developing therapies for neurodegenerative diseases. The company is listed on the stock market under the ticker symbol ALEC, with a market capitalization of approximately $194.3 million. Alector aims to advance its innovative treatments to address unmet medical needs in the field of neuroscience.